{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:19:18Z","timestamp":1793949558428,"version":"4.8.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004836","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.xcrm.2026.102906","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:44:55Z","timestamp":1783439095000},"page":"102906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Preventative semaglutide and tirzepatide treatment does not alter disease progression in the 5xFAD mouse model of Alzheimer's disease"],"prefix":"10.1016","volume":"7","author":[{"given":"Anika","family":"Vear","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie Amalie","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie Cathrine Holst","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Amalie","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2456-9667","authenticated-orcid":false,"given":"Christoffer","family":"Clemmensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102906_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","article-title":"Alzheimer disease","volume":"7","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.xcrm.2026.102906_bib2","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1016\/S0140-6736(24)01883-X","article-title":"Passive anti-amyloid beta immunotherapy in Alzheimer's disease-opportunities and challenges","volume":"404","author":"Heneka","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2026.102906_bib3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2022.12.032","article-title":"Hallmarks of neurodegenerative diseases","volume":"186","author":"Wilson","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102906_bib4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s42255-025-01263-4","article-title":"Incretin-based therapeutics for the treatment of neurodegenerative diseases","volume":"7","author":"Vear","year":"2025","journal-title":"Nat. Metab."},{"key":"10.1016\/j.xcrm.2026.102906_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/JCI194751","article-title":"Antiinflammatory actions of glucagon-like peptide-1-based therapies beyond metabolic benefits","volume":"135","author":"Wong","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.xcrm.2026.102906_bib6","article-title":"Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: Data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers","volume":"8","author":"N\u00f8rgaard","year":"2022","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.xcrm.2026.102906_bib7","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/S0140-6736(26)00459-9","article-title":"Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials","volume":"407","author":"Cummings","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2026.102906_bib8","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbr.2015.07.024","article-title":"Prophylactic liraglutide treatment prevents amyloid plaque deposition, chronic inflammation and memory impairment in APP\/PS1 mice","volume":"293","author":"McClean","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.xcrm.2026.102906_bib9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2013.08.005","article-title":"Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP\/PS1 mice, a model of Alzheimer's disease","volume":"76","author":"McClean","year":"2014","journal-title":"Neuropharmacology 76 Pt"},{"key":"10.1016\/j.xcrm.2026.102906_bib10","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1007\/s11064-017-2250-8","article-title":"Liraglutide Improves Water Maze Learning and Memory Performance While Reduces Hyperphosphorylation of Tau and Neurofilaments in APP\/PS1\/Tau Triple Transgenic Mice","volume":"42","author":"Chen","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.xcrm.2026.102906_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101180","article-title":"GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in Alzheimer's disease","volume":"47","author":"Zheng","year":"2021","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.xcrm.2026.102906_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111529","article-title":"Glucagon-like peptide-1 analogs mitigate neuroinflammation in Alzheimer's disease by suppressing NLRP2 activation in astrocytes","volume":"542","author":"Zhang","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.xcrm.2026.102906_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2016.04.052","article-title":"Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3beta pathway in an amyloid beta protein induced alzheimer disease mouse model","volume":"783","author":"Qi","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.102906_bib14","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.3892\/etm.2016.3742","article-title":"Exendin-4 antagonizes Abeta1-42-induced attenuation of spatial learning and memory ability","volume":"12","author":"Wang","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.xcrm.2026.102906_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.physbeh.2016.03.016","article-title":"Exendin-4, a glucagon-like peptide 1 receptor agonist, protects against amyloid-beta peptide-induced impairment of spatial learning and memory in rats","volume":"159","author":"Jia","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.xcrm.2026.102906_bib16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3233\/JAD-130584","article-title":"The neuroprotection of liraglutide on Alzheimer-like learning and memory impairment by modulating the hyperphosphorylation of tau and neurofilament proteins and insulin signaling pathways in mice","volume":"37","author":"Xiong","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.xcrm.2026.102906_bib17","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3233\/JAD-143090","article-title":"The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease","volume":"46","author":"Hansen","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.xcrm.2026.102906_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109716","article-title":"Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer's disease via the GLP-1R\/SIRT1\/GLUT4 pathway","volume":"240","author":"Wang","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.xcrm.2026.102906_bib19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neuroscience.2024.11.022","article-title":"Semaglutide promotes the transition of microglia from M1 to M2 type to reduce brain inflammation in APP\/PS1\/tau mice","volume":"563","author":"Wang","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.xcrm.2026.102906_bib20","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/13872877251329439","article-title":"Semaglutide improves cognitive function and neuroinflammation in APP\/PS1 transgenic mice by activating AMPK and inhibiting TLR4\/NF-kappaB pathway","volume":"105","author":"Zhai","year":"2025","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.xcrm.2026.102906_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.102019","article-title":"The GLP-1 medicines semaglutide and tirzepatide do not alter disease-related pathology, behaviour or cognitive function in 5XFAD and APP\/PS1 mice","volume":"89","author":"Forny Germano","year":"2024","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.xcrm.2026.102906_bib22","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.3390\/ijms22105365","article-title":"A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer's Disease, the 5XFAD Mouse","volume":"22","author":"L\u00f3pez-Gambero","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2026.102906_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.713726","article-title":"Comprehensive Evaluation of the 5XFAD Mouse Model for Preclinical Testing Applications: A MODEL-AD Study","volume":"13","author":"Oblak","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.xcrm.2026.102906_bib24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/gbb.12133","article-title":"Abnormal vibrissa-related behavior and loss of barrel field inhibitory neurons in 5xFAD transgenics","volume":"13","author":"Flanigan","year":"2014","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.xcrm.2026.102906_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.149122","article-title":"Early spatial recognition memory deficits in 5XFAD female mice are associated with disruption of prefrontal parvalbumin neurons","volume":"1841","author":"Ganesh","year":"2024","journal-title":"Brain Res."},{"key":"10.1016\/j.xcrm.2026.102906_bib26","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s42003-019-0599-8","article-title":"3D mapping reveals network-specific amyloid progression and subcortical susceptibility in mice","volume":"2","author":"Gail Canter","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.xcrm.2026.102906_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41597-021-01054-y","article-title":"Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer's disease","volume":"8","author":"Forner","year":"2021","journal-title":"Sci. Data"},{"key":"10.1016\/j.xcrm.2026.102906_bib28","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3390\/biom14101294","article-title":"Comprehensive Analysis of the 5xFAD Mouse Model of Alzheimer's Disease Using dMRI, Immunohistochemistry, and Neuronal and Glial Functional Metabolic Mapping","volume":"14","author":"Westi","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.xcrm.2026.102906_bib29","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41598-018-19807-y","article-title":"Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer's Disease and Mild Cognitive Impairment: A Two-year Follow-up Study","volume":"8","author":"Lee","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102906_bib30","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nm1555","article-title":"Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease","volume":"13","author":"El Khoury","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102906_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/JCI152565","article-title":"Peripheral monocyte-derived cells counter amyloid plaque pathogenesis in a mouse model of Alzheimer's disease","volume":"132","author":"Yan","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.xcrm.2026.102906_bib32","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1038\/s41598-019-42286-8","article-title":"Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice","volume":"9","author":"Zhao","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102906_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1742-2094-5-37","article-title":"Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation","volume":"5","author":"Lee","year":"2008","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.xcrm.2026.102906_bib34","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.3390\/ijms23042377","article-title":"Amyloid Beta Pathology Exacerbates Weight Loss and Brain Cytokine Responses following Low-Dose Lipopolysaccharide in Aged Female Tg2576 Mice","volume":"23","author":"Knopp","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2026.102906_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2020.112891","article-title":"Recognition memory impairments and amyloid-beta deposition of the retrosplenial cortex at the early stage of 5XFAD mice","volume":"222","author":"Kim","year":"2020","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.xcrm.2026.102906_bib36","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1532-5415.1998.tb04537.x","article-title":"The association of weight change in Alzheimer's disease with severity of disease and mortality: a longitudinal analysis","volume":"46","author":"White","year":"1998","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.xcrm.2026.102906_bib37","article-title":"Neurodegeneration emerges at a cellular tipping point between aggregate accumulation and removal","author":"Cotton","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2026.102906_bib38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41591-025-04106-7","article-title":"Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial","volume":"32","author":"Edison","year":"2026","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102906_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114187","article-title":"Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics","volume":"180","author":"Salameh","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.102906_bib40","article-title":"Brain uptake pharmacokinetics of albiglutide, dulaglutide, tirzepatide, and DA5-CH in the search for new treatments of Alzheimer's and Parkinson's diseases","volume":"12","author":"Rhea","year":"2023","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.xcrm.2026.102906_bib41","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266637912600323X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266637912600323X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:07:55Z","timestamp":1784646475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266637912600323X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S266637912600323X"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102906","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventative semaglutide and tirzepatide treatment does not alter disease progression in the 5xFAD mouse model of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102906"}}